Firefly Neuroscience (AIFF) Capital Expenditures (2010 - 2026)

Firefly Neuroscience's Capital Expenditures history runs 16 years deep, the most recent figure standing at $58000.0 for Q1 2026.

• In Q1 2026, Capital Expenditures rose 728.57% year-over-year to $58000.0; the TTM figure through Mar 2026 stood at $179000.0 (up 28.78% YoY), while the FY2025 annual figure was $128000.0, down 13.51% from the prior year.
• Capital Expenditures was $58000.0 for Q1 2026 at Firefly Neuroscience, up from $23000.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $301842.0 in Q4 2022 to a low of $7000.0 in Q1 2025.
• Historically, Capital Expenditures has averaged $77627.5 across 4 years, with a median of $58000.0 in 2026.
• The sharpest annual moves came in 2022 and 2025: Capital Expenditures soared 2096.17% in 2022, then tumbled 81.25% in 2025.
• A 4-year view of Capital Expenditures shows it stood at $301842.0 in 2022, then slumped by 77.47% to $68000.0 in 2024, then slumped by 66.18% to $23000.0 in 2025, then surged by 152.17% to $58000.0 in 2026.
• The last three Capital Expenditures figures came in at $58000.0 (Q1 2026), $23000.0 (Q4 2025), and $86000.0 (Q3 2025), per Business Quant data.